Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
09/2008
09/12/2008WO2008073461A3 Ion channel modulators
09/12/2008CA2678895A1 Tricyclic compounds useful in treating iron disorders
09/11/2008US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation
09/11/2008US20080220285 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices
09/10/2008EP1966182A1 Inhibitors of ccr9 activity
09/10/2008EP1966148A1 Carboxamides
09/10/2008EP1966147A1 Carboxamides for controlling micro-organisms in plant and material protection
09/10/2008EP1965642A2 Pyrazolyl carboxamides
09/10/2008CN101260100A Preparation method for 5-hydroxymethylthiazole
09/10/2008CN100417653C Preparation method of thienotetrahydropyridinacetic acid and salt thereof
09/09/2008US7423061 Anticarcinogenic agents; tert-butyl 3-{[(2-[(aminocarbonyl)amino]-5-{4-[2-(diethylamino)ethoxy]phenyl}-3-thienyl)carbonyl]amino}piperidine-1-carboxylate
09/09/2008US7423060 Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors
09/09/2008US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid
09/09/2008US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/09/2008CA2211646C Substituted phenyl compounds as endothelin antagonists
09/04/2008WO2007054776A3 Stilbene like compounds as novel hdac inhibitors
09/04/2008US20080214838 Oligo-Tetracenes, Production and Use Thereof
09/04/2008US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic
09/04/2008US20080214654 Substituted Benzyloxy-Phenylmethylamide Derivatives
09/04/2008US20080214635 Modulation of pathogenicity
09/04/2008US20080214612 for therapy of endometriosis and/or uterine leiomyoma/leiomyomata; 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine
09/04/2008US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
09/03/2008EP1964842A1 5H-THIENO [3,4-c]PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR
09/03/2008EP1964838A1 Process for the resolution of homocysteine-thiolactone
09/03/2008EP1641774B1 Pentafluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
09/03/2008CN101258147A Derivatives of 4-piperazin-1-yl-4-benz0[B]thiophene suitable for the treatment of CNS disorders
09/03/2008CN101258138A Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands
09/03/2008CN101255117A Non-steroidal antiphlogiston prodrug with nitric oxide donor and preparation method thereof
09/03/2008CN101255090A Synthesis of alpha, beta, beta-trifluorostyrene via in-situ for mation or trifluorovinyl metal halide
09/03/2008CN100415750C Fungicides for the control of take-all disease of plants
09/03/2008CN100415735C Amino alcohol derivatives
09/03/2008CN100415729C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420065 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/02/2008US7419986 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
09/02/2008US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes
09/02/2008CA2283126C Method for preparing 2-thienylethylamine derivatives
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
09/02/2008CA2248338C 2-amino-4-bicycloamino-1,3,5-triazines as herbicides and plant growth regulators
09/02/2008CA2160447C Amino(thio)ether derivatives
08/2008
08/28/2008WO2008102908A1 Haloalkylsulfonanilide derivative
08/28/2008WO2008101976A1 Fungicide n-(3-phenylpropyl)carboxamide derivatives
08/28/2008WO2008101806A2 High refractive index monomers, compositions and uses thereof
08/28/2008US20080207923 Forming duloxetine, or salt thereof; serotonine receptor antagonist
08/28/2008US20080207922 Condensation Compound Between Fluorinated Cyclopentane Ring and Aromatic Ring, and Process for Producing the Same
08/28/2008US20080207741 Chronic onstructive pulmonary disease; adult respiratory distress syndrome; antiinflammatory agents; skin disorders; autoimmune diseases; multiple sclerosis; antihistamines; inflammatory bowel disorders
08/28/2008US20080207740 Small organic molecule regulators of cell proliferation
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080206824 Method For Producing Optically Active Alcohols From Alkanones Using a Dehydrogenase of Azoarcus
08/27/2008EP1962354A1 Organic electroluminescence element material and organic electroluminescence element using same
08/27/2008EP1960395A1 Plasminogen activator inhibitor-1 inhibitors
08/27/2008EP1960379A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
08/27/2008EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/27/2008EP1960353A2 Prostaglandins and analogues as agents for lowering intraocular pressure
08/27/2008EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors
08/27/2008EP1960343A2 Indene derivatives, their preparation and use as medicaments
08/27/2008EP1799636B1 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
08/27/2008EP1620431B1 3-carbonylaminothiophenes and their use as fungicides
08/27/2008EP1606275B1 Opioid receptor antagonists
08/27/2008CN101250136A 1,3-diaryl-3-aryl amidine-1-acetoxime compounds, preparation method and use thereof
08/27/2008CN101250134A N-aryl-beta-aryl amidine-propionamide compounds, preparation method and use thereof
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413861C Compounds and methods for the treatment or prevention of flavivirus infections
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/26/2008US7417067 mixtures of bicyclic compounds such as lubiprostone, and triglycerides; bronchodilator agents; eye drops, capsules
08/26/2008US7417066 Inhibitors of soluble adenylate cyclase
08/26/2008US7417065 Therapy, prevention of lymphocyte causing disease; antiinflammatory agents; autoimmune disease
08/26/2008US7417064 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
08/26/2008CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
08/26/2008CA2392165C Vitamin d analogues
08/21/2008WO2008100867A2 Novel inhibitors hepatitis c virus replication
08/21/2008WO2008100800A1 Bioavailable formulations of heterocyclic compounds
08/21/2008WO2008024978A3 Tetrahydroindolone and tetrahydroindazolone derivatives
08/21/2008WO2007095200A3 A process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate
08/21/2008US20080200535 Amine Compounds
08/21/2008US20080200525 Pesticidally active ketone and oxime derivatives
08/21/2008US20080200468 2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists
08/21/2008CA2676906A1 Novel inhibitors hepatitis c virus replication
08/20/2008EP1957459A2 Iminopropene compound and use thereof
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1956909A1 Microbiocides
08/20/2008EP1956907A2 Cyanobenzene compounds for combating animal pests
08/20/2008EP1569647B1 Cyclohexyl compounds as ccr5 antagonists
08/20/2008EP1539731B9 Novel compounds
08/20/2008EP1459765B1 6-fluorobicyclo 3.1.0 hexane derivatives
08/20/2008EP1249233B1 Npyy5 antagonists
08/20/2008CN101247722A Biphenyl-N- (4-pyridyl) methylsulfonamides
08/20/2008CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
08/19/2008US7414064 Pesticides for crops; agriculture, horticulture
08/14/2008WO2008096094A1 Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators
08/14/2008US20080194878 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors
08/14/2008US20080194842 chlorovinyl or fluorovinyl groups on phenyl or thiophene rings; reacting a substituted or unsubstituted aromatic or heteroaromatic Grignard reagent with a 1,1-dihaloalkene; 4-bromo-2-dimethoxymethyl-5-(1-fluorovinyl)-3-methylthiophene; excellent yields; simple work-up and purification procedures
08/14/2008US20080194670 Novel Thiophene Derivatives as Spingosine-1-Phosphate-1 Receptor Agonists
08/14/2008US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents
08/14/2008US20080194637 Small organic molecule regulators of cell proliferation
08/14/2008US20080194608 Atherosclerosis therapy; antidiabetic agents; dyslipidemia
08/14/2008US20080194607 Modulation of pathogenicity
08/14/2008US20080194597 Platelet adp receptor inhibitors
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 329